Abstract: A method for managing an object-based storage system is provided. The object-based storage system includes root objects, partition objects, collection objects, user objects and function objects. The function objects include user function objects and system function objects. The user function objects respond to the client request, so that the existing data-processing tasks requested by the client are moved to the OBSD to be completed, so as to achieve the purposes for saving the network storage bandwidth and improving the security of the stored data, etc. The system function objects execute the system management function, so that the management of the bottom of disks management of the file system and database system is completed by the OBSD. That can be easily realized in automatic data backup, load balancing and other functions in the storage system. The user function objects and system function objects can be customized by the user.

Abstract: The present invention relates to a personal cleansing composition with an antimicrobial effect. The personal cleansing composition is in the form of a bar soap and contains zinc pyrithione and a soap surfactant. When dispersed in an aqueous solution at 1 wt %, the personal cleansing composition of the present invention is characterized by a pH value ranging that is higher than about 9.6 and lower than about 10.3. The present invention also relates to a process for forming an antimicrobial bar soap as described hereinabove.

Abstract: The present invention is concerned with a solid delivery form of elinogrel for the treatment of thrombosis which is notable for its multi-pH dissolution, immediate release and improved pharmacokinetic properties and stability in storage. The delivery and dosage form is a solid, oral formulation comprising: a) at least about 15% by weight elinogrel or a pharmaceutically acceptable salt thereof relative to the total weight of the overall pharmaceutical composition, and b) at least one pharmaceutically acceptable carrier. A further aspect of the present invention concerns the preparation and use of such a formulation.

Abstract: The present invention is concerned with a liquid delivery form of Elinogrel for the treatment of thrombosis which is notable for its improved dosage properties and stability. The dosage form is a liquid or a lyophilized form which is reconstituted for an injectable formulation comprising: a) at least about 3 mg/ml or up to about 15 mg/ml Elinogrel or a pharmaceutically acceptable salt thereof (post reconstitution or in liquid form), and b) at least one pharmaceutically acceptable excipient. Further aspects of the present invention concern the preparation and use of such a formulation.

Abstract: A removing tool used for removing a removable element from a shielding cover. The removing tool comprises a handle including a first end and a head protruding from the first end, a driving portion mounted on the head, and a pushing portion mounted on the head between the driving portion and the first end. The driving portion is for latching with the removable element; the pushing portion pushes the removable element away from the shielding cover until the removable element separates from the shielding cover.

Abstract: A bar soap comprising a pyrithione source, a soap surfactant, and a pH adjusting agent selected from a group consisting of ammonia solution, triethanolamine, diethanolamine, monoethanolamine, potassium hydroxide, sodium hydroxide, soluble carbonate salts, and combinations thereof, wherein the bar soap attains a pH of greater than or equal to 10.7. A process of inhibiting the formation of a discoloration in a bar soap comprising pyrithione sources by adding pH adjusting agent to attain a pH of greater than or equal to 10.7. A process of inhibiting the formation of a discoloration in a bar soap caused by dissolved ferric ions and/or cupric ions and pyrithione sources in the bar, comprising the step of adding from about 0.3% to about 20% soluble carbonate salt during manufacturing of the bar soap.

Abstract: Razors comprising a shaving aid comprising a soap base and a pyrithione source.

Abstract: The present invention provides novel sulfonylurea salts of a salt of formula (I) and polymorph forms thereof. The compounds in their various forms are effective platelet ADP receptor inhibitors and may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of cardiovascular diseases, particularly those diseases related to thrombosis. The invention also provides a method for preparing such compounds and forms and for preventing or treating thrombosis and thrombosis related conditions in a mammal comprising the step of administering a therapeutically effective amount of a salt of formula (I) or a pharmaceutically acceptable form thereof.

Abstract: A battery cover latching mechanism employed in an electronic device is used to assemble a battery cover to a housing. The battery cover latching mechanism includes a hook, a base body, a sliding element, and an operating element. The hook is mounted on the battery cover, and the base body is detachably assembled to the housing. The sliding element is detachably and slidably assembled to the base body and includes a latching block corresponding to the hook. The operating element is detachably assembled to the sliding element, and is pushed relative to the sliding element, the operating element forces the sliding element to move relative to the base body, the latching block unlocks the hook to detach the battery cover, when the latching block locks the hook, the battery cover is latched.

Abstract: A removing tool used for removing a removable element from a shielding cover. The removing tool comprises a handle including a first end and a head protruding from the first end, a driving portion mounted on the head, and a pushing portion mounted on the head between the driving portion and the first end. The driving portion is for latching with the removable element; the pushing portion pushes the removable element away from the shielding cover until the removable element separates from the shielding cover.

Abstract: A method for managing an object-based storage system is provided. The object-based storage system includes root objects, partition objects, collection objects, user objects and function objects. The function objects include user function objects and system function objects. The user function objects respond to the client request, so that the existing data-processing tasks requested by the client are moved to the OBSD to be completed, so as to achieve the purposes for saving the network storage bandwidth and improving the security of the stored data, etc. The system function objects execute the system management function, so that the management of the bottom of disks management of the file system and database system is completed by the OBSD. That can be easily realized in automatic data backup, load balancing and other functions in the storage system. The user function objects and system function objects can be customized by the user.

Abstract: The present invention provides crystalline forms of a mesylate salt of the compound 5-chloro-N-((1-(4-(2-oxopyridin-1(2H)-yl)phenyl)-1H-imidazol-4-yl)methyl)thiophene-2-carboxamide and pharmaceutical compositions and methods thereof.

Abstract: A database system and a method of optimizing cross-database query. The database system includes a plurality of databases. At least two of the databases are stored with one or more data collections composed of tables with the same structure. A federated view of the data collection is created on each of the databases. A request routing layer for routing, in response to a query request crossing the data collections, the query request crossing the data collections to one of the at least two databases according to a predetermined routing rule, so as to query by using the federated view of the database.

Abstract: A novel solid composition and methods for making and using the solid composition are provided. The solid composition comprises: (a) at least one active agent with a solubility of less than about 0.3 mg/ml in an aqueous solution with a pH of at most about 6.8 at a temperature of about 37° C.; and (b) a hydrophilic polymer matrix composition comprising: i) a hydrophilic polymer selected from the group consisting of METHOCEL™, POLYOX™ WSR 1105 and combinations thereof; and optionally ii) a hydrophobic polymer selected from the group consisting of Ethocel 20 premium; and (c) an alkalizer selected from the group consisting of calcium carbonate, magnesium oxide heavy and sodium bicarbonate; wherein the composition provides at least about 70% release of the active between about 7 to about 12 hours following oral administration.

Abstract: An electronic device and method for conserving power of a global position system (GPS) include setting a time interval to acquire movement parameters of the electronic device, and activating the GPS and a three-axis accelerometer to acquire the movement parameters of the electronic device. The electronic device and method further include determining if the electronic device is at rest, maintaining an active state of the GPS if the electronic device is not at rest, or disabling the GPS if the electronic device is at rest.

Abstract: Taught is a method of removal surface contaminants, including organic contaminants, metal ions and solid particles, from silicon wafer surface comprising the following steps: (a) submerging the silicon wafer surface in an aqueous cleaning agent solution through which current is passed using a boron-doped diamond film as an electrode; (b) submerging the silicon wafer surface in an aqueous cleaning agent solution; subjecting the silicon wafer to ultrasound waves; and, optionally, heating the solution; (c) submerging the silicon wafer surface in water through which current is passed using a boron-doped diamond film as an electrode; (d) submerging the silicon wafer surface in water with ultrasound and heating; (e) repeating step (d); and (f) spraying the silicon surface with water. The results obtained using the method according to this invention are far superior to those obtained with conventional methods. The technology is simple, convenient to operate, and environmentally friendly.

Abstract: A device, system and method is invented to solidify data from temporary storage media to long term storage media without intervention of computer. Those who can not access computer are enabled to use digital recording apparatus, such as digital camera. The operation of the device is restricted in order to increase the ease of use, and to provide the core function. The core function is to read data from temporary storage media, such as various memory cards, and write the data to long term storage media, such as user-writeable CD or DVD. The device features a minimal set of hardware components for accomplishing this function, such as a simplified user interface, an embedded processor, a data reading channel, and a data solidification channel. A data play mode can also be optionally implemented for the user to check the solidified data.

Abstract: Provided are certain methods of treating nonalcoholic fatty liver disease with farnesoid X receptor agonists. Also provided are certain methods of modulating levels of keratinocyte-derived chemokine (KC), alanine aminotransferase (ALT), aspartate aminotransferase (AST), cytokeratin 18 (CK-18), matrix metalloproteinase-9 (MMP-9), matrix metalloproteinase-14 (MMP-14), tissue inhibitor of metalloproteinase 1 (TIMP-1), and Cytochrome P450 2E1 (CYP2E1); certain methods of identifying FXR modulators; and certain methods of treating patients with existing cholesterol gallstone disease.

Abstract: The present invention provides novel sulfonylurea salts of a salt of formula (I) and polymorph forms thereof. The compounds in their various forms are effective platelet ADP receptor inhibitors and may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of cardiovascular diseases, particularly those diseases related to thrombosis. The invention also provides a method for preparing such compounds and forms and for preventing or treating thrombosis and thrombosis related conditions in a mammal comprising the step of administering a therapeutically effective amount of a salt of formula (I) or a pharmaceutically acceptable form thereof.